LabCompass

Jian Zhu

Medicine · The Ohio State University

OpenAlex ORCID
Established · publishing since 1996
Cancer-related Molecular PathwaysHippo pathway signaling and YAP/TAZDiabetes Treatment and ManagementRegulation of Appetite and ObesityCancer-related molecular mechanisms research

Publications

17

Citations

793

Est. group size

—

Recurring co-author estimate

Active years

30

Publishing since 1996

Research summary
AI-generated

Jian Zhu's research focuses on molecular signaling pathways involved in cancer, particularly how the Hippo pathway and its effector protein YAP interact with hormone signaling (estrogen receptor) and other cellular regulators to influence tumor growth in breast cancer and kidney cancer (ccRCC). Recent work also touches on the immune effects of proton radiotherapy in cancer treatment. This research aims to identify molecular targets that could inform future cancer therapies.

Hippo pathway and YAP signaling in cancerBreast cancer molecular biologyEstrogen receptor signaling in cancerCancer cell metabolism and hypoxia signaling (HIF pathways)Radiotherapy and tumor immunology

Publication output was concentrated in a burst in 2022 with additional activity in 2025, following an apparent gap earlier in the decade, suggesting an irregular rather than steady publication cadence.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 1.6/year recently
17181920212022: 5 publications52223242025: 3 publications2526
Recent publications
Publishes in
  • Nature Communications×1
  • Cancer Innovation×1
  • Frontiers in Immunology×1
  • Cell Discovery×1
  • Cell Death and Disease×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile